Internal Medicine, Endocrinology, Diabetes, & Metabolism · Carolina, PR
NPI
1750309456
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Ave Monserrate, Ac - 5
Carolina, PR, 00985
Phone (787) 757-3720
Medicare paid, 2024
$4,937
86 services
Medicare patients, 2024
48
Average age 78
Drug cost, 2024
$4.8M
16,962 prescriptions
Company payments, 2023
$20.32
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica I Rosa was code 99214 (office e&m - established), 80 times for 47 patients. In total Jessica I Rosa billed 86 services in 3 codes, and Medicare paid $4,937.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 80 | 47 | $55.94 | $4,475 |
By year: 2022 $6,278 for 113 services; 2023 $5,941 for 106 services; 2024 $4,937 for 86 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica I Rosa prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 3,385 prescriptions and refills. In total Jessica I Rosa wrote 16,962 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 3,385 | 6,474 | 662 | $283K |
| Gabapentin Generic | 903 | 1,558 | 232 | $11K |
| Glimepiride Generic | 815 | 1,363 | 175 | $9,307 |
| Metformin Hcl Er Metformin Hcl | 797 | 1,691 | 220 | $7,124 |
| Trulicity Dulaglutide | 781 | 913 | 116 | $907K |
| Atorvastatin Calcium Generic | 747 | 1,520 | 228 | $7,379 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 629 | 878 | 127 | $532K |
| Ozempic Semaglutide | 498 | 544 | 83 | $511K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 467 | 543 | 89 | $330K |
| Farxiga Dapagliflozin Propanediol | 410 | 555 | 88 | $321K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 379 | 529 | 90 | $297K |
| Metformin Hcl Generic | 360 | 725 | 102 | $2,383 |
| Rosuvastatin Calcium Generic | 353 | 715 | 113 | $4,137 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 343 | 445 | 68 | $33K |
| Tradjenta Linagliptin | 334 | 456 | 70 | $240K |
Brand drugs: 9,428 claims; generic drugs: 7,229 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Jessica I Rosa $20.32 ($20.32 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $20.32.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $20.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.